Bevacizumab versus Ranibizumab on As-Needed Treatment Regimen for Neovascular Age-Related Macular Degeneration in Turkish Patients

Table 4

Mean number of injections.

	Bevacizumab group	Ranibizumab group	P value
First year	4.8±1.2 (range 3–7)	4.7±1.4 (range 3–8)	0.8
Second year	0.9±1.2 (range 0–5)	1.3±1.4 (range 0–4)	0.1
Total	5.7±2.0 (range 3–11)	6.0±2.3 (range 3–12)	0.3